The Endocrine Society today issued a Clinical Practice Guideline (CPG) advising against the usage of testosterone treatment in healthy women. Although the FDA approved testosterone therapy for the treatment of diseases involving the testes, pituitary and hypothalamus, it hasn't been approved for treating age-related declines in testosterone levels. The U.S. National Institute on Aging is also anticipated to release the results of research on the safety of testosterone. The study involved roughly 800 elderly men with low testosterone and symptoms associated with this illness, like http://tinyurl.com/jrdad8y
physical and sexual dysfunction. Since the heart health of the men was monitored, the research is expected
to shed more light on the safety of testosterone therapy.
Studies have shown that testosterone deficiency is associated with several important health issues like obesity, diabetes, metabolic syndrome, and bone fractures Guys who meet medical
standards for treatment should receive therapy. In fact, your testosterone levels have probably been slowly declining for some time, a decline that generally starts around age 30.
And many women have a knee jerk suspicion that any hormone treatment can increase their risk of breast cancer. However, clinical studies show that testosterone not only does not raise a woman's risk of breast cancer , it may play a vital role in warding off the disease. Glaser believes this will likely stay the status quo for a while, given the prohibitive cost of conducting the long term safety studies needed to win FDA approval that is fuller.